News

Geron Corp. quits stem cell work

 

The Menlo Park-based biotechnology firm Geron Corp. announced recently that it was abandoning its stem cell research in favor of focusing on two cancer drugs.

The motivation appears financial, according to a statement issued by the company.

"The decision to narrow Geron's technology and therapeutic focus was made after a strategic review of the costs, value inflection timelines and clinical, manufacturing and regulatory complexities," the company said.

As a result, 66 jobs -- 38 percent of its workforce -- will be eliminated, the company said.

The news came as a blow to those hoping to benefit from stem cell therapy, a field that held promise for those paralyzed by spinal cord injuries.

Stem cells possess the ability to become any other type of cell in the body, leading Geron's scientists to explore how to grow the cells into replacement neurons that could reverse paralysis.

Comments

Sorry, but further commenting on this topic has been closed.

I AM THE GOD OF HELL FIRE AND I BRING YOU
By Laura Stec | 29 comments | 1,739 views

Are We Really Up To This?
By Aldis Petriceks | 1 comment | 1,126 views

Nobu Palo Alto eyes next-door expansion
By Elena Kadvany | 0 comments | 1,043 views

Couples: Initiators and Implementors
By Chandrama Anderson | 0 comments | 788 views

Don't be a ghost
By Cheryl Bac | 0 comments | 521 views